Pharma Journalist -

Merck, known as MSD outside the U.S. and Canada, announced positive results from its Phase 3 STRIDE-13 trial evaluating CAPVAXIVE, its 21-valent pneumococcal conjugate vaccine, in…
Read More...

Kashiv BioSciences, LLC has announced a licensing and supply agreement with Brazilian pharmaceutical giant CRISTÁLIA for the commercialization of ADL-018, a proposed biosimilar to…
Read More...

Scipher Medicine, known for its AI-driven precision immunology platform, has announced a strategic collaboration with Maxymune Therapeutics, a biotech company focused on novel…
Read More...

Kytopen Corp., a leader in continuous flow cellular engineering, has announced a collaboration with BlueWhale Bio, a company focused on advancing cell-based therapies by revolutionizing…
Read More...

In a sweeping move to restore public trust in pharmaceutical advertising, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) today…
Read More...

Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INLEXZO (gemcitabine intravesical system), a novel treatment for adults with Bacillus…
Read More...

Teva Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational therapy emrusolmin (TEV-56286) for the…
Read More...

Novartis announced it has agreed to acquire Tourmaline Bio, a clinical-stage biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 monoclonal antibody designed to…
Read More...

Medison and Ipsen announced that Health Canada has approved Bylvay (odevixibat) for the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille Syndrome…
Read More...

Servier, an international pharmaceutical group, has announced the acquisition of KER-0193, a promising potential treatment for Fragile X syndrome (FXS) from UK-based biotech Kaerus…
Read More...